Abstract
A study was undertaken to document supply and value chain of three important medicinal plants Embelia tsjeriam cottam, Celastrus paniculatus and Centratherum anthelminticum. Value chain analysis (VCA) was done from village level, district, regional to national level covering primary producers (n-144), market traders (n-20) and processors. Supply chains for three species were mapped and value chains covering most activities as produce moved across to industries were covered. The study revealed that the three species were mostly extracted from the wild and of these two species Embelia tsjerian-cottam and Celastrus paniculatus were facing depletion. There is an unfair margin to traders, with producers’ shares ranging between 35-50% which is low. Suggestions have been given to mitigate problems in the marketing channel.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
